Glucovision (Citrate) (2020-05-11)
- Starting date:
- May 11, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Radiopharmaceuticals
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- Healthcare Professionals, Hospitals, General Public
- Identification number:
- RA-73167
Last updated: 2020-05-21
Summary
-
Product:
Glucovision (Citrate) 453 GBq/vial
Reason
Affected lot contains ethanol levels outside of the labelled claim.
Depth of distribution
Healthcare establishments
Affected products
Glucovision (Citrate) 453 GBq/vial
DIN, NPN, DIN-HIM
DIN 02328771
Dosage form
Solution
Strength
Fludeoxyglucose 18F 453 GBq/vial
Lot or serial number
T-200511FDG-1
Companies
- Recalling Firm
-
Centre for Probe Development and Commercialization (CPDC)
1280 Main St. W. NRB-A316
Hamilton
L8S 4K1
Ontario
CANADA
- Marketing Authorization Holder
-
Centre for Probe Development and Commercialization (CPDC)
1280 Main St. W. NRB-A316
Hamilton
L8S 4K1
Ontario
CANADA